Metropolitan Life Insurance Company (MetLife)’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,106
| Closed | -$55.6K | – | 1444 |
|
|
2024
Q1 | $55.6K | Buy |
6,106
+1,905
| +45% | +$17.3K | ﹤0.01% | 1350 |
|
|
2023
Q4 | $18.7K | Hold |
4,201
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q3 | $13.2K | Hold |
4,201
| – | – | ﹤0.01% | 2090 |
|
|
2023
Q2 | $21.7K | Hold |
4,201
| – | – | ﹤0.01% | 1886 |
|
|
2023
Q1 | $22.1K | Sell |
4,201
-465
| -10% | -$2.45K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $13.1K | Hold |
4,666
| – | – | ﹤0.01% | 2192 |
|
|
2022
Q3 | $19.4K | Buy |
4,666
+2,243
| +93% | +$9.31K | ﹤0.01% | 2045 |
|
|
2022
Q2 | $9.74K | Sell |
2,423
-2,625
| -52% | -$10.6K | ﹤0.01% | 2311 |
|
|
2022
Q1 | $25K | Sell |
5,048
-13,656
| -73% | -$67.6K | ﹤0.01% | 1988 |
|
|
2021
Q4 | $130K | Sell |
18,704
-1,300
| -6% | -$9.06K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $200K | Hold |
20,004
| – | – | ﹤0.01% | 2069 |
|
|
2021
Q2 | $284K | Buy |
20,004
+2,027
| +11% | +$28.7K | ﹤0.01% | 1901 |
|
|
2021
Q1 | $295K | Sell |
17,977
-824
| -4% | -$13.5K | ﹤0.01% | 1758 |
|
|
2020
Q4 | $389K | Hold |
18,801
| – | – | 0.01% | 1525 |
|
|
2020
Q3 | $143K | Buy |
18,801
+3,551
| +23% | +$27K | ﹤0.01% | 1993 |
|
|
2020
Q2 | $127K | Buy |
15,250
+408
| +3% | +$3.4K | ﹤0.01% | 2110 |
|
|
2020
Q1 | $73.5K | Buy |
+14,842
| New | +$73.5K | ﹤0.01% | 2227 |
|
|
2018
Q3 | – | Sell |
-12,259
| Closed | -$82.7K | – | 2612 |
|
|
2018
Q2 | $82.7K | Buy |
+12,259
| New | +$82.7K | ﹤0.01% | 2396 |
|
|
2017
Q3 | – | Sell |
-17,157
| Closed | -$159K | – | 2508 |
|
|
2017
Q2 | $159K | Buy |
+17,157
| New | +$159K | ﹤0.01% | 2459 |
|
|
2015
Q4 | – | Sell |
-9,887
| Closed | -$139K | – | 2618 |
|
|
2015
Q3 | $139K | Hold |
9,887
| – | – | ﹤0.01% | 2514 |
|
|
2015
Q2 | $208K | Buy |
+9,887
| New | +$208K | ﹤0.01% | 2375 |
|